Biogen’s Alzheimer’s results bolster tau theory—and Denali’s next gen candidate

If Biogen has shown that tau can impact cognition, Denali’s technology—validated with an FDA approval in Hunter syndrome—could ensure the medicine gets where it needs to be for the greatest therapeutic impact, analysts said.